The future of medicine is being written today. The 11th Medtech Innovation Event, held September 1st in Biel, Switzerland, brought together startups, SMEs, investors, service providers, and academics in the medtech sector for a comprehensive day of networking, knowledge sharing, and innovation showcase.

AI & MedTech Collaboration Ecosystem

The event’s core mission was to foster the partnerships necessary to translate innovative ideas into real-world medical solutions.

The event featured a keynote by Adrian Hunn, Director of Swiss Medtech, on “Global Pressures, Local Innovation: How Medtech Adapts,” highlighting trends and challenges in the medtech landscape. Updates on key projects from the Swiss HealthTech Center and funding opportunities via Euresearch’s Horizon Europe program provided valuable insights for participants. A key panel session titled “Start-up – Investor – Hospital” explored the critical dynamics of funding and commercialization, featuring experts from hospitals, innovation hubs, and medtech companies.

There was also a pitching session, during which six Swiss medtech startups, including Clee Medical and Hemetron AG, presented their breakthrough technologies. 

Innovative developments in medical devices capable of detecting human cognitive states were prominently featured at the event. Among the breakthroughs were advancements in Parkinson’s disease treatment, showcasing specialized sensors that target specific brain regions to stop patients’ hands from trembling. 

A specialized device was presented that allows patients who require frequent blood tests—up to 12 times a day—to undergo these procedures painlessly and with minimal discomfort. The core networking activity was a matchmaking session, which enabled participants to engage in focused one-to-one meetings, fostering collaboration and partnerships. 

Exploring MedTech Synergies

Navigating the complex landscape of regulatory compliance is a critical step for any company developing AI-enabled medical devices. One of the steps that First Line Software and our Clinovera division specialize in is guiding startups and established firms through this process. Our RegulationAI tool is specifically designed to manage the ever-evolving guidelines set by regulatory bodies like the European Medicines Agency (EMA), ensuring your project remains compliant and on track.

A key focus for Clinovera is working directly with medtech companies to implement tailored AI solutions that drastically improve operational efficiency. By integrating AI into areas like predictive maintenance of equipment and automated patient unstructured data management, Clinovera helps healthcare organisations and institutions reduce costs, accelerate time-to-market, and enhance the overall performance of their medical technologies. 

Ilia Blaer, Operational Director from First Line Software, met with colleagues to discuss these possibilities and emerging medtech solutions and explore opportunities within this vibrant ecosystem. Notably, they examined an innovative EEG wearable hat designed for real-time brain activity monitoring developed by EEG / Neuroana, an Australian company. This wearable device, paired with a mobile app, uses AI-driven analysis based on TensorFlow to assess mental states such as stress, focus, and relaxation, offering personalized recommendations to improve mental well-being. 

First Line Software and Clinovera showcased AI as the foundation of the next-generation healthcare infrastructure to our medtech colleagues. Ilia Blaer discussed a trio of targeted AI solutions addressing some of the healthcare industry’s toughest challenges: Managed AI Services for end-to-end AI implementation, an AI platform that automates complex clinical documentation structuring, and RegulationAI, designed to simplify and speed up regulatory compliance processes.

Our participation highlighted an industry transition from isolated AI experiments toward fully integrated, managed AI platforms that prioritize innovation, reliability, and real operational benefits. By focusing on improving clinical documentation accuracy and regulatory agility, First Line Software’s AI tools are positioned as essential to healthcare organizations aiming to modernize operations and reduce administrative burdens.

Future Outlook

Even more promising for cancer patients, new technologies now enable rapid assessment of which medications are effective, significantly aiding the fight against the disease. 

As the healthcare division of First Line Software, Clinovera holds strong potential in the region to leverage technology breakthroughs to improve healthcare delivery, benefiting both clinical institutions and patients alike. Our mission is to partner with medtech innovators to drive transformative healthcare innovation through advanced, efficiency-focused AI solutions and strategic collaborations. 

Contact us today to explore how we can collaborate to deliver leading-edge results.